Prognostic Role of TEAD4 in TNBC: In-silico Inhibition of the TEAD4-YAP Interaction by Flufenamic Acid Analogs

Overview

Journal In Silico Pharmacol

Date 2024 Jul 22

PMID 39035099

Authors

Shradheya R R Gupta

Shivani Singh

Vanshika Rustagi

Monika Pahuja

Irengbam Rocky Mangangcha

Moses Rinchui

Saurabh K Jha

Archana Singh

Indrakant K Singh

Affiliations

Soon will be listed here.

Abstract

Graphical Abstract:

Supplementary Information: The online version contains supplementary material available at 10.1007/s40203-024-00239-8.

References

Taha Z, Janse van Rensburg H, Yang X . The Hippo Pathway: Immunity and Cancer. Cancers (Basel). 2018; 10(4). PMC: 5923349. DOI: 10.3390/cancers10040094. View

Goel M, Khanna P, Kishore J . Understanding survival analysis: Kaplan-Meier estimate. Int J Ayurveda Res. 2011; 1(4):274-8. PMC: 3059453. DOI: 10.4103/0974-7788.76794. View

Hsu S, Lin C, Lin Y, Collins C, Chen C, Kung H . TEAD4 as an Oncogene and a Mitochondrial Modulator. Front Cell Dev Biol. 2022; 10:890419. PMC: 9117765. DOI: 10.3389/fcell.2022.890419. View

Yong J, Li Y, Lin S, Wang Z, Xu Y . Inhibitors Targeting YAP in Gastric Cancer: Current Status and Future Perspectives. Drug Des Devel Ther. 2021; 15:2445-2456. PMC: 8203099. DOI: 10.2147/DDDT.S308377. View

Genheden S, Ryde U . The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discov. 2015; 10(5):449-61. PMC: 4487606. DOI: 10.1517/17460441.2015.1032936. View

Lee K, Bharadwaj S, Sahoo A, Yadava U, Kang S . Determination of tyrosinase-cyanidin-3-O-glucoside and (-/+)-catechin binding modes reveal mechanistic differences in tyrosinase inhibition. Sci Rep. 2021; 11(1):24494. PMC: 8718538. DOI: 10.1038/s41598-021-03569-1. View

Wang Z, Kong Q, Su P, Duan M, Xue M, Li X . Regulation of Hippo signaling and triple negative breast cancer progression by an ubiquitin ligase RNF187. Oncogenesis. 2020; 9(3):36. PMC: 7083878. DOI: 10.1038/s41389-020-0220-5. View

Abdul-Hammed M, Adedotun I, Olajide M, Irabor C, Afolabi T, Gbadebo I . Virtual screening, ADMET profiling, PASS prediction, and bioactivity studies of potential inhibitory roles of alkaloids, phytosterols, and flavonoids against COVID-19 main protease (M). Nat Prod Res. 2021; 36(12):3110-3116. PMC: 8204315. DOI: 10.1080/14786419.2021.1935933. View

Bissanum R, Chaichulee S, Kamolphiwong R, Navakanitworakul R, Kanokwiroon K . Molecular Classification Models for Triple Negative Breast Cancer Subtype Using Machine Learning. J Pers Med. 2021; 11(9). PMC: 8472680. DOI: 10.3390/jpm11090881. View

10.

Li Y, Zong R, Zhang H, Meng X, Wu F . Mechanism Analysis of LINC00665 and Its Peptides CIP2A-BP in Hepatocellular Carcinoma. Front Genet. 2022; 13:861096. PMC: 8957827. DOI: 10.3389/fgene.2022.861096. View

11.

He L, Yuan L, Sun Y, Wang P, Zhang H, Feng X . Glucocorticoid Receptor Signaling Activates TEAD4 to Promote Breast Cancer Progression. Cancer Res. 2019; 79(17):4399-4411. DOI: 10.1158/0008-5472.CAN-19-0012. View

12.

Feau C, Arnold L, Kosinski A, Zhu F, Connelly M, Guy R . Novel flufenamic acid analogues as inhibitors of androgen receptor mediated transcription. ACS Chem Biol. 2009; 4(10):834-43. PMC: 2763043. DOI: 10.1021/cb900143a. View

13.

Giraud J, Molina-Castro S, Seeneevassen L, Sifre E, Izotte J, Tiffon C . Verteporfin targeting YAP1/TAZ-TEAD transcriptional activity inhibits the tumorigenic properties of gastric cancer stem cells. Int J Cancer. 2019; 146(8):2255-2267. DOI: 10.1002/ijc.32667. View

14.

Chen L, Chan S, Zhang X, Walsh M, Lim C, Hong W . Structural basis of YAP recognition by TEAD4 in the hippo pathway. Genes Dev. 2010; 24(3):290-300. PMC: 2811830. DOI: 10.1101/gad.1865310. View

15.

Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z . GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017; 45(W1):W98-W102. PMC: 5570223. DOI: 10.1093/nar/gkx247. View

16.

Grant B, Skjaerven L, Yao X . The Bio3D packages for structural bioinformatics. Protein Sci. 2020; 30(1):20-30. PMC: 7737766. DOI: 10.1002/pro.3923. View

17.

Song S, Xie M, Scott A, Jin J, Ma L, Dong X . A Novel YAP1 Inhibitor Targets CSC-Enriched Radiation-Resistant Cells and Exerts Strong Antitumor Activity in Esophageal Adenocarcinoma. Mol Cancer Ther. 2017; 17(2):443-454. PMC: 5805581. DOI: 10.1158/1535-7163.MCT-17-0560. View

18.

Zhang Y, Wang J, Liu X . LRRC19-A Bridge between Selenium Adjuvant Therapy and Renal Clear Cell Carcinoma: A Study Based on Datamining. Genes (Basel). 2020; 11(4). PMC: 7230350. DOI: 10.3390/genes11040440. View

19.

Suvorov A . Simple method for cutoff point identification in descriptive high-throughput biological studies. BMC Genomics. 2022; 23(1):204. PMC: 8922865. DOI: 10.1186/s12864-022-08427-6. View

20.

Hollingsworth S, Dror R . Molecular Dynamics Simulation for All. Neuron. 2018; 99(6):1129-1143. PMC: 6209097. DOI: 10.1016/j.neuron.2018.08.011. View